
Beta 2 Glycoprotein 1 IgM, Serum









The Beta 2 Glycoprotein 1 IgM, Serum is a blood test that helps detect the presence of immunoglobulin M (IgM) antibodies targeting Beta 2 Glycoprotein 1 (β2GPI), a protein found in abundance in the blood plasma. These antibodies are often linked to autoimmune conditions like antiphospholipid syndrome (APS), where they can contribute to an increased risk of blood clots, miscarriage, and other health complications.













Understanding Beta 2 Glycoprotein 1 IgM, Serum
Beta 2 Glycoprotein 1 (β2GPI) is a protein that helps with blood clotting. In individuals with autoimmune conditions like antiphospholipid syndrome (APS), the immune system mistakenly makes antibodies against β2GPI, called anti-β2GPI antibodies. The Beta 2 Glycoprotein 1 IgM, Serum test checks for these antibodies in the blood, which is important for diagnosing and managing APS.
APS is a disorder where the immune system produces antibodies against parts of the cell membrane, increasing the chance of forming abnormal blood clots. These clots can cause serious complications like deep vein thrombosis (DVT), pulmonary embolism (PE), stroke, heart attack, and recurrent miscarriages. The Beta 2 Glycoprotein 1 IgM, Serum test helps find these antibodies, so doctors can diagnose APS and start the right treatment.
This test is often recommended for individuals who have unexplained blood clots, repeated pregnancy losses, or signs of antiphospholipid syndrome (APS), like strokes or miscarriages. It is also helpful for checking how well treatment is working in individuals with APS or autoimmune diseases like lupus (SLE), which can have similar antibodies. For those with a history of repeated blood clots or pregnancy problems, the test helps assess the risk of clotting and guide treatment decisions. It is also useful for detecting APS early, as the presence of IgM antibodies can indicate an active or recent autoimmune response.
No special preparation is needed before the Beta 2 Glycoprotein 1 IgM, Serum test. However, inform the doctor about all the medications or supplements being taken, as a few of them may affect the test results, potentially requiring dosage adjustments or temporary discontinuation before the test.
Lab test results may vary across different laboratories. Abnormal test results require an expert interpretation. Therefore, never try to self-medicate at home based solely on these results. Always consult a doctor for a proper understanding of the test results. The insights from this test help the doctor tailor an appropriate treatment plan.
What does Beta 2 Glycoprotein 1 IgM, Serum measure?
The Beta 2 Glycoprotein 1 IgM, Serum test checks for the presence of immunoglobulin M (IgM) antibodies against Beta 2 Glycoprotein 1, a protein that helps regulate blood clotting. IgM antibodies are usually the first type of antibody the body makes in response to new infections or autoimmune issues. Elevated IgM (Immunoglobulin M) levels can indicate an ongoing or recent infection, or they can suggest an autoimmune response. In the context of pregnancy, high IgM levels might be associated with certain conditions like antiphospholipid syndrome or other immune-related issues that could affect pregnancy outcomes. When doctors notice high IgM levels, particularly in pregnant women, it can guide decisions like monitoring the pregnancy more closely for signs of complications, including preterm labor or fetal growth restrictions, considering blood thinners (like heparin or aspirin), especially if the patient is at risk of clotting disorders, which are associated with higher IgM levels in some cases and checking for infections (e.g., TORCH infections) that could pose risks to the baby.





FAQs related to Beta 2 Glycoprotein 1 IgM, Serum
- McDonnell T, Wincup C, Buchholz I, Pericleous C, Giles I, Ripoll V, Cohen H, Delcea M, Rahman A. The role of beta-2-glycoprotein I in health and disease associating structure with function: More than just APS. Blood Rev. 2020 Jan;39:100610. [Accessed 18 Nov. 2024] Available from:
- Beta2 Glycoprotein 1 [Internet]. ScienceDirect; [Accessed 18 Nov. 2024] Available from:
- Ortel TL. Antiphospholipid syndrome: laboratory testing and diagnostic strategies. Am J Hematol. 2012 May;87 Suppl 1(Suppl 1):S75-81. [Accessed 18 Nov. 2024]. Available from:
- Bustamante JG, Goyal A, Singhal M. Antiphospholipid Syndrome. [Updated 2023 Feb 7]. In: StatPearls [Internet]. Treasure Island (FL): StatPearls Publishing; 2024 Jan-. Available from:
- BLOOD CLOTTING DISORDERS [Internet]. NIH; 24 Mar. 2022. [Accessed 18 Nov. 2024]. Available from: [Accessed 18 Nov. 2024]. Available from:
Other tests
- PT INR (Prothrombin Time with INR)
- HIV 1 and 2 Antibody, Rapid Screening Test
- Viral Marker Screening (HIV, HBsAg, Anti-HCV)
- Total IgE
- Rheumatoid Factor - Quantitative
- STD Panel (Sexually Transmitted Diseases Panel)
- HIV Combo (Antigen And Antibody) Test
- Anti-CCP Antibody
- Lipid Profile, Non Fasting
- Anti-Nuclear Antibody (ANA) by IFA - End Point Titer
- CBC (Complete Blood Count)
- FBS (Fasting Blood Sugar)
- Thyroid Profile Total (T3, T4 & TSH)
- HbA1c (Glycosylated Hemoglobin)
- PPBS (Postprandial Blood Sugar)
- Lipid Profile
- Vitamin D (25-Hydroxy)
- Urine R/M (Urine Routine & Microscopy)
- Coronavirus Covid -19 test- RT PCR
- LFT (Liver Function Test)
- KFT (Kidney Function Test)
- TSH (Thyroid Stimulating Hormone) Ultrasensitive
- ESR (Erythrocyte Sedimentation Rate)
- Uric Acid, Serum
- Vitamin B12
- CRP (C-Reactive Protein), Quantitative
- Urine C/S (Urine Culture and Sensitivity)
- Serum Electrolytes
- Serum Calcium
- Serum Creatinine
- Diabetes Screening (HbA1C & Fasting Sugar)
- KFT with Electrolytes (Kidney Function Test with Electrolytes)
- Cholesterol - Total
- Hb (Hemoglobin)
- Complete Hemogram (CBC & ESR)
























